484 related articles for article (PubMed ID: 3492971)
1. Isolation and analysis of complement activating aggregates from synovial fluid of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies.
Bedwell AE; Elson CJ; Carter SD; Dieppe PA; Hutton CW; Czudek R
Ann Rheum Dis; 1987 Jan; 46(1):55-64. PubMed ID: 3492971
[TBL] [Abstract][Full Text] [Related]
2. Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis.
Elson CJ; Carter SD; Cottrell BJ; Scott DG; Bacon PA; Wallington TB
Clin Exp Immunol; 1985 Feb; 59(2):285-92. PubMed ID: 3978872
[TBL] [Abstract][Full Text] [Related]
3. C1q-bearing immune complexes detected by a monoclonal antibody to human C1q in rheumatoid arthritis sera and synovial fluids.
Antes U; Heinz HP; Schultz D; Brackertz D; Loos M
Rheumatol Int; 1991; 10(6):245-50. PubMed ID: 2041983
[TBL] [Abstract][Full Text] [Related]
4. Complement C3c and C3d in plasma and synovial fluid in rheumatoid arthritis.
Berkowicz A; Kappelgaard E; Petersen J; Nielsen H; Ingemann-Hansen T; Halkjaer-Kristensen J; Sørensen H
Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):397-402. PubMed ID: 6608857
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
Aguado MT; Lambris JD; Tsokos GC; Burger R; Bitter-Suermann D; Tamerius JD; Dixon FJ; Theofilopoulos AN
J Clin Invest; 1985 Oct; 76(4):1418-26. PubMed ID: 2932466
[TBL] [Abstract][Full Text] [Related]
6. Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monocylonal rheumatoid factor.
Luthra HS; McDuffie FC; Hunder GG; Samayoa EA
J Clin Invest; 1975 Aug; 56(2):458-66. PubMed ID: 125289
[TBL] [Abstract][Full Text] [Related]
7. Fibronectin binding with immunoglobulin aggregates and its association with rheumatic disorders.
Carter SD; Scott DL; Elson CJ
Br J Rheumatol; 1986 Nov; 25(4):353-8. PubMed ID: 3490895
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin phagocytosis by granulocytes from sera and synovial fluids in various rheumatoid and nonrheumatoid diseases.
Cats A; Lafeber GJ; Klein F
Ann Rheum Dis; 1975 Apr; 34(2):146-55. PubMed ID: 806270
[TBL] [Abstract][Full Text] [Related]
9. Elevated autoantibody content in rheumatoid arthritis synovia with lymphoid aggregates and the effect of rituximab.
Rosengren S; Wei N; Kalunian KC; Zvaifler NJ; Kavanaugh A; Boyle DL
Arthritis Res Ther; 2008; 10(5):R105. PubMed ID: 18761748
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of circulating immune complexes in patients with rheumatoid arthritis.
Perego R; Vezzoli S; Manfredi W; Bigi G; Procaccia S
Boll Ist Sieroter Milan; 1983 Nov; 62(5):462-8. PubMed ID: 6608359
[TBL] [Abstract][Full Text] [Related]
11. Concentrations of glycosaminoglycans in synovial fluids and their relation with immunological and inflammatory mediators in rheumatoid arthritis.
Bensouyad A; Hollander AP; Dularay B; Bedwell AE; Cooper RA; Hutton CW; Dieppe PA; Elson CJ
Ann Rheum Dis; 1990 May; 49(5):301-7. PubMed ID: 2344209
[TBL] [Abstract][Full Text] [Related]
12. Complement-activating properties of IgM rheumatoid factors reacting with IgG subclasses.
Sato Y; Watanabe H; Kogure A; Miyata M; Watanabe K; Nishimaki T; Kasukawa R; Fujita T
Clin Rheumatol; 1995 Jul; 14(4):425-8. PubMed ID: 7586979
[TBL] [Abstract][Full Text] [Related]
13. Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.
Nydegger UE; Zubler RH; Gabay R; Joliat G; Karagevrekis CH; Lambert PH; Miescher PA
J Clin Invest; 1977 May; 59(5):862-8. PubMed ID: 853126
[TBL] [Abstract][Full Text] [Related]
14. Immune complex detection and complement activity in rheumatoid arthritis: a comparative study of a radioimmunoassay using monoclonal rheumatoid factor, gel diffusion techniques and C4 activity.
Halla JT; Volanakis JE; Hardin JG; Schrohenloher RE
Clin Exp Immunol; 1978 Nov; 34(2):226-34. PubMed ID: 737907
[TBL] [Abstract][Full Text] [Related]
15. Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals.
Biró E; Nieuwland R; Tak PP; Pronk LM; Schaap MC; Sturk A; Hack CE
Ann Rheum Dis; 2007 Aug; 66(8):1085-92. PubMed ID: 17261534
[TBL] [Abstract][Full Text] [Related]
16. Rheumatoid factor isotypes and circulating immune complexes in rheumatoid arthritis.
Zlabinger GJ; Haberhauer G; Dax K; Menzel EJ; Bröll H
Clin Exp Rheumatol; 1990; 8(2):113-9. PubMed ID: 2338008
[TBL] [Abstract][Full Text] [Related]
17. Depressed degranulation response of synovial fluid polymorphonuclear leucocytes from patients with rheumatoid arthritis to IgG aggregates.
Dularay B; Dieppe PA; Elson CJ
Clin Exp Immunol; 1990 Feb; 79(2):195-201. PubMed ID: 2155727
[TBL] [Abstract][Full Text] [Related]
18. [Complement (C3)-activating material in synovial fluid from patients with rheumatoid arthritis].
Stojan B
Z Rheumatol; 1981; 40(5):208-12. PubMed ID: 6914866
[TBL] [Abstract][Full Text] [Related]
19. Human IgG rheumatoid factors and RF-like immune complexes induce IgG1 rheumatoid factor production in mice.
Abedi-Valugerdi M; Ridderstad A; al-Balaghi S; Möller E
Scand J Immunol; 1995 Jun; 41(6):575-82. PubMed ID: 7770728
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of complement-fixing rheumatoid synovial fluid immune complexes.
Male DK; Roitt IM
Clin Exp Immunol; 1981 Dec; 46(3):521-9. PubMed ID: 7337979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
